NASDAQ : CRVS

Corvus Pharmaceuticals, Inc.

$14.27 USD

-$0.65 (-4.36%)

Volume
1.24M
Average Volume
1.6M
Market Capitalization
$1.2B
P/E Ratio
-25.95
Dividend Yield
0.00%
Price Target
$31.00
Year High
$26.95
Year Low
$3.96
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$19.81

CRVS Estimated and Actual Revenue by Quarter

CRVS Estimated and Actual EPS by Quarter

CRVS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 2 - - - - - -
2027-09-30 2 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 2 -17.89M -17.89M -17.89M - - -
2027-09-30 2 -17.8M -17.8M -17.8M - - -
2027-06-30 0 -18.2M -18.2M -18.2M - - -
2027-03-31 0 -17.91M -17.91M -17.91M - - -
2026-12-31 0 -17.78M -17.78M -17.78M - - -
2026-09-30 0 -15.74M -15.74M -15.74M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 2 4.15M 4.15M 4.15M 1 -0.19875 -0.19875 -0.19875
2027-09-30 2 3.05M 3.05M 3.05M 1 -0.19775 -0.19775 -0.19775
2027-06-30 0 - - - 1 -0.20225 -0.20225 -0.20225
2027-03-31 0 - - - 1 -0.199 -0.199 -0.199
2026-12-31 0 - - - 1 -0.19751 -0.19751 -0.19751
2026-09-30 0 - - - 2 -0.17493 -0.17493 -0.17493